SCHEMBL9631967

SCHEMBL9631967

CC(C)=CCC/C(C)=C/CC/C(C)=C/CCCC(P(=O)(O)O)P(=O)(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sq-34919 SCHEMBL9632769 1.00
Sq-34919 SCHEMBL9633342 1.00
Sq-34919 SCHEMBL9632781 1.00
SCHEMBL9631973 1.00
SCHEMBL9633372 0.95
SCHEMBL9632023 0.95
SCHEMBL9632034 0.95
SCHEMBL9633364 0.95
SCHEMBL9633118 0.94
SCHEMBL9634119 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0513761-A2 Bisphosphonate squalene synthetase inhibitors E.R. SQUIBB &amp; SONS, INC. (US) 1992-11-19 EP claimed
US-5157027-A Anticholesterol agents E. R. SQUIBB & SONS, INC. (US) 1992-10-20 US claimed
EP-0513761-A2 Bisphosphonate squalene synthetase inhibitors E.R. SQUIBB &amp; SONS, INC. (US) 1992-11-19 EP disclosed
US-5157027-A Anticholesterol agents E. R. SQUIBB & SONS, INC. (US) 1992-10-20 US disclosed